课题基金 / 基金详情

Development of array based comparative genomic hybridization (CGH) as a diagnostic tool for cryptic chromosome aberrations in congenital disorders

Development of array based comparative genomic hybridization (CGH) as a diagnostic tool for cryptic chromosome aberrations in congenital disorders
开发基于阵列的比较基因组杂交(CGH)作为先天性疾病中隐性染色体畸变的诊断工具
批准号:
17390099
负责人:
INAZAWA Johji
金额:
$9.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

INAZAWA Johji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The human genome sequencing project had been conducted successfully, with 99% of the genome sequenced with 99.99% accuracy. In the post-sequence era, detection of disease-related genomic alterations is directly connected with identification of genes associated with multiple congenital anomalies with mental retardation (MCA/MR), autism, and other unknown genomic disorders. However, we had none of tools for exploring cryptic chromosome aberrations at 100kb-level. In order to overcome the situation, we have constructed high-resolution CGH-arrays as follows, (1) Whole Genome Array (WGA)-4500, which contains 4523 BACs throughout the whole genome, (2) Cancer Array-800, which harbors 800 BACs for different cancer-related genes, (3) 1p36-contig array, which covers about 20Mb spanning 1p36 region with 212 BACs, (4) Chromosome X-tiling array, which contains 1001 BACs throughout chromosome X except pseudo-autosomal region, and (5) Genome Disorder (GD)-array, which is employed as the diagnostic tool for known genomic disorders. Using those in-house BAC arrays, we explored cryptic chromosome aberrations in a large number of patients with MCA/MR, and detected de novo submicroscopic aberrations related to the pathogenesis of unknown MCA/MR in some of those patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ajmg.a.31770
发表时间: 2007-06-15
期刊: AMERICAN JOURNAL OF MEDICAL GENETICS PART A
影响因子: 2
作者: [Tokutomi, Tomoharu, Hayashi, Shin, Nonoyama, Shigeaki]
通讯作者: Nonoyama, Shigeaki
DOI: --
发表时间: 2006
期刊: Annals of neurology
影响因子: 11.2
作者: [K. Nishioka;Shin Hayashi;M. Farrer;A. Singleton;H. Yoshino;H. Imai;Toshiaki Kitami;Kenichi Sato;R. Kuroda;H. Tomiyama;K. Mizoguchi;M. Murata;T. Toda;I. Imoto;J. Inazawa;Y. Mizuno;N. Hattori]
通讯作者: K. Nishioka;Shin Hayashi;M. Farrer;A. Singleton;H. Yoshino;H. Imai;Toshiaki Kitami;Kenichi Sato;R. Kuroda;H. Tomiyama;K. Mizoguchi;M. Murata;T. Toda;I. Imoto;J. Inazawa;Y. Mizuno;N. Hattori
Clinical and molecular cytogenetic characterization od two patients with non-mutational aberrations of the FMR2 gene.
两名 FMR2 基因非突变畸变患者的临床和分子细胞遗传学特征。
DOI: --
发表时间: 2007
期刊: Am J Med Genet.A 143
影响因子: --
作者: [Honda S, Inazawa J, et al.]
通讯作者: et al.
食道癌の検出方法
如何发现食道癌
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: []
通讯作者:
35
    Innovative development of DDS for microRNA therapeutics by an application of anti-PCSK9 antibody
    • 批准号:
      16K14630
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2016
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Chromothripsis-like pattern in cancer-cell genome after irradiation by a focused vertical micro-beam system, SPICE
    • 批准号:
      25640062
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Development of diagnostic tools for personalized cancer medicine by genomic and epigenomic analyses
    • 批准号:
      22240090
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.12万
    • 财政年份:
      2010
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Integrative genomics and epigenomics for personalized cancer medicine
    • 批准号:
      17015012
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $74.56万
    • 财政年份:
      2005
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    海外基金